A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.
Clinical trial NCT01821677 · COMPLETED
Trial details
- NCT number
- NCT01821677
- Sponsor
- Ampio Pharmaceuticals. Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-26
- Primary completion
- 2014-10-30
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.